TRIM24 upregulates ORM2 to alleviate abnormal lipid metabolism, inflammation, and oxidative stress in mice with obstructive sleep apnea syndrome & metabolic dysfunction-associated steatotic liver disease.

Obstructive sleep apnea syndrome (OSAS) is associated with the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Tripartite Motif Containing 24 (TRIM24) deficiency was reported to cause hepatic lipid accumulation and hepatitis. However, the expression, function, and mechanism of TRIM24 in OSAS & MASLD remain unclear. OSAS & MASLD mouse model was established by intermittent hypoxia (IH) & high-fat diet. IH- & 1% free fatty acid-induced mouse liver cells were served as in vitro model. TRIM24 and HIF-1α were upregulated under IH condition. HIF-1α enhanced the transcriptional activity of TRIM24. Overexpression of TRIM24 reduced hepatic lipid accumulation, decreased serum levels of TC, TG, and LDL-C, and increased serum levels of HDL-C in OSAS & MASLD mice. Additionally, overexpression of TRIM24 alleviated inflammation, oxidative stress, and modulated aberrant lipid metabolism. Mechanically, TRIM24 upregulated the expression of ORM2, a key regulator of hepatic lipogenesis, by binding to H3K27ac and recruiting RAR-alpha to ORM2 promoter. The cell rescue model verified that ORM2 mediated the hepatoprotective effects of TRIM24. Our evidence reveals the important role of TRIM24 as an epigenetic co-regulator of transcription in OSAS & MASLD, providing additional insights into understanding the pathogenesis and preventing the development of OSAS & MASLD.

• Publication year

  2024

• Venue

  American Journal of Pathology

• Publication date

  2024-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.ajpath.2024.07.020PMID 39168366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.

  2023cited by this paper
• Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)

  2023cited by this paper
• Macrophages: From Simple Phagocyte to an Integrative Regulatory Cell for Inflammation and Tissue Regeneration—A Review of the Literature

  2023cited by this paper
• Quantitative proteomics of HFD-induced fatty liver uncovers novel transcription factors of lipid metabolism

  2022cited by this paper
• Dysregulated m6A Modification Promotes Lipogenesis and Development of Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma.

  2022cited by this paper
• Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation

  2022cited by this paper
• Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis

  2022cited by this paper
• TRIM24 is an insulin-responsive regulator of P-bodies

  2022cited by this paper
• Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD

  2021cited by this paper
• E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase‐1/IL‐1β‐mediated pyroptosis in endometriosis

  2021cited by this paper
• 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade

  2021cited by this paper
• Combined intermittent and sustained hypoxia is a novel and deleterious cardio-metabolic phenotype.

  2021cited by this paper
• TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination

  2020cited by this paper
• Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.

  2020cited by this paper
• Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein

  2020cited by this paper
• The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome

  2020cited by this paper
• Sleep-disordered Breathing and Free Fatty Acid Metabolism.

  2020cited by this paper
• Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation

  2019cited by this paper
• Role of acute‐phase protein ORM in a mice model of ischemic stroke

  2019cited by this paper
• Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

  2019cited by this paper
• Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH

  2019cited by this paper
• Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease

  2019cited by this paper
• Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.

  2019cited by this paper
• Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines

  2019cited by this paper
• Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians

  2018cited by this paper
• Nocturnal Hypoxia Improves Glucose Disposal, Decreases Mitochondrial Efficiency, and Increases Reactive Oxygen Species in the Muscle and Liver of C57BL/6J Mice Independent of Weight Change

  2018cited by this paper
• Born to run: control of transcription elongation by RNA polymerase II

  2018cited by this paper
• ApoA‐1 accelerates regeneration of small‐for‐size fatty liver graft after transplantation

  2018cited by this paper
• The role of hypoxia-inducible factors in metabolic diseases

  2018cited by this paper
• T-cell–intrinsic Tif1α/Trim24 regulates IL-1R expression on TH2 cells and TH2 cell-mediated airway allergy

  2016cited by this paper
• Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome.

  2016cited by this paper
• TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

  2016cited by this paper
• HIF‐1 at the crossroads of hypoxia, inflammation, and cancer

  2016cited by this paper
• Hypoxia-inducible factors as molecular targets for liver diseases

  2016cited by this paper
• Effect of hypoxia on UDP-glucuronosyl transferase mRNA expression in human hepatocarcinoma functional liver celL4 cell line.

  2016cited by this paper
• Obstructive sleep apnoea syndrome

  2015cited by this paper
• A Metabolic Stress-inducible miR-34a-HNF4α Pathway Regulates Lipid and Lipoprotein Metabolism

  2015cited by this paper
• Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon

  2015cited by this paper
• TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.

  2015cited by this paper
• AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease

  2014cited by this paper
• Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth.

  2014cited by this paper
• All‐trans‐retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade

  2014cited by this paper
• TRIM24 Is a p53-Induced E3-Ubiquitin Ligase That Undergoes ATM-Mediated Phosphorylation and Autodegradation during DNA Damage

  2014cited by this paper
• Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation*

  2013cited by this paper
• Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression

  2012cited by this paper
• Obstructive Sleep Apnea–Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms

  2012cited by this paper
• Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Is the Liver Another Target?

  2012cited by this paper
• Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

  2012cited by this paper
• TRIM24 links a noncanonical histone signature to breast cancer

  2010cited by this paper
• Adipose Tissue Dysfunction Signals Progression of Hepatic Steatosis Towards Nonalcoholic Steatohepatitis in C57Bl/6 Mice

  2010cited by this paper
• Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

  2010cited by this paper
• Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.

  2009cited by this paper
• Sleep, sleep-disordered breathing and metabolic consequences

  2009cited by this paper
• TRIM family proteins and their emerging roles in innate immunity

  2008cited by this paper
• Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

  2007cited by this paper
• Association between lipid peroxidation and inflammation in obstructive sleep apnoea

  2006cited by this paper
• Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats.

  2005cited by this paper
• Retinoic acid receptor α dominant negative form causes steatohepatitis and liver tumors in transgenic mice

  2004cited by this paper
• HNF4: A central regulator of hepatocyte differentiation and function

  2003cited by this paper
• Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.

  2003cited by this paper
• Obstructive sleep apnoea syndrome--an oxidative stress disorder.

  2003cited by this paper
• Obstructive sleep apnea is independently associated with insulin resistance.

  2002cited by this paper
• C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

  2001cited by this paper
• Hypoxia‐inducible factor‐1α (HIF‐1α) escapes O2‐driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm

  2001cited by this paper
• Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm.

  2001cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.

  1996cited by this paper
• Obstructive sleep apnoea syndrome.

  1995cited by this paper

• The Predictive Value of TyG-BMI and TG/HDL-C for Metabolic Dysfunction-Associated Steatotic Liver Disease in Obstructive Sleep Apnea: A Single-Center Retrospective Cohort Analysis

  2026cites this paper
• Advances in the study of mechanisms underlying olfactory dysfunction in obstructive sleep apnea:a narrative review

  2025cites this paper
• Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside

  2025cites this paper
• TRIM24 regulates chromatin remodeling and calcium dynamics in cardiomyocytes

  2025cites this paper
• Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma

  2025cites this paper
• Exploration of molecular mechanism of baicalin targeting TRIM24 to suppress NLRP3/caspase-1-mediated chondrocyte pyroptosis in osteoarthritis based on network pharmacology and molecular docking.

  2025cites this paper
• Single Nucleus MultiOmics Links Novel Transcription Factor Motifs to Murine Hepatic Sex Differences in Chromatin Accessibility and Metabolic Dysfunction-Associated Steatotic Liver Disease

  2025cites this paper
• HDI-STARR-seq Identifies Functional GH-regulated Sex-Biased Hepatocyte Enhancers Linked to Liver Metabolism and Disease

  2025cites this paper
• Emerging roles of TRIM in metabolic regulation.

  2025cites this paper